Interim Guidance 31 march 2020
WHO has established a shipment mechanism to expedite and cover the costs of the shipment of clinical samples from patients with suspected COVID-19 from the country of collection to one of the WHO reference laboratories providing confirmatory molecular testing for COVI...D-19. This document explains the process and documentation required for shipment of specimens.
more
This document is a guide for national authorities who are responsible for managing public health responses to COVID-19
Primary care can play a significant role in the COVID-19 response by differentiating patients with respiratory symptoms from those with COVID-19, making an early diagnosis, helping vulnerable people cope with their anxiety about the virus, and reducing the demand for hospital services. This document... provides national and subnational health managers, as well as staff at primary care facilities, with interim guidance on timely, effective and safe supportive management of patients with suspected and confirmed COVID-19 at the primary care level; and delivery of essential health services at the primary care level during the COVID-19 outbreak
more
The interim Emergency Response Preparedness (ERP) guidance is designed to be a short technical step-by-step guide aimed at non-Humanitarian Response Plan (HRP) countries to support the development, or strengthening, of preparedness measures to ensure that country teams are operationally ready to imp...lement activities to address the potential non-health impacts of the COVID-19 pandemic and its compound effect on existing risks. The interim guidance is based on the IASC 2015 ERP Guidance.
more
Throughout the gestational period, it is important for obstetric health care facilities to strengthen health counselling, screening, and follow-ups for pregnant women, while incorporating screening, hand hygiene practice, good respiratory etiquette and infection prevention control precautions. These... screening procedures will help determine individualised precautions necessary, such as the wearing of face masks during consultations.
more
Prescriptions and Actionables for a Healthy and Green Recovery.
The practical steps outlined in this report aim at creating a healthier, fairer and greener world while investing to maintain and resuscitate the economy hit by the effects of COVID-19.
Policy makers, national and local decision-make...rs and a wide array of other actors wishing to contribute to a healthy recovery can now take decisive steps by shaping the way we live, work and consume. Effects on environmental degradation and pollution and climate change will be wide ranging. WHO and partner organizations have since long been developing substantive guidance and provide support for building healthier environments for healthier populations.
more
Updated 20 Nov. 2020
Countries can use this checklist of hospital governance, structures, plans and protocols to rapidly determine the current capacities of hospitals to respond to the COVID-19 pandemic and to identify gaps and major areas that require investment and action for the development of h...ospital readiness improvement plans. The tool can be used periodically to monitor hospital emergency operational readiness capacity development
more
Иммунизация является важной медицинской услугой, которая защищает человечество от болезней, предупреждаемых вакцинацией (БПВ)2. Благодаря своевременной имму...низации люди и сообщества обретают защиту, и вероятность вспышки БПВ уменьшается.Предотвращение вспышки БПВ не только спасает жизни, но и требует меньше ресурсовпо сравнению среагированиемна вспышку и помогает снизить нагрузку на систему здравоохранения, и без того перегруженную в результате пандемии COVID-19.
more
The Lancet DOI: 10.1016/S2468-2667(20)30101-8
WHO declared COVID-19 to be a pandemic on March 11, 2020. The pandemic eventually reached Yemen, with the first laboratory confirmed case announced on April 10. emen has structural vulnerabilities that have developed over a protracted period of conflic...t and poor governance, and its health system has suffered the most. To prevent a total collapse of Yemen’s fragile health system, the government and the international community should act now more decisively.
more
Усиление мер реагированиясистем здравоохранения на COVID-19: техническое руководство No 5: адаптация первичной медико-санитарной помощи для повышения эффективности о...ветных мер в связи с COVID-19 (17 июня 2020 г.)
Strengthening the health systems response to COVID-19: technical guidance
more
This document has been developed to assist National Societies in deciding if and how they may wish to assist their government’s strategy for contact tracing as part of their response plan for COVID-19.
21 August 2020
This guidance provides specific considerations for the use of non-medical masks, also known as fabric masks, by children as a means for source control in the context of the current COVID-19 pandemic. It also advises on the use of medical masks for children under certain conditions.
Sepsis remains a leading cause of mortality and morbidity, especially during the first five days of life and in low and middle-income countries (LMIC) [1]. Hospital infection also remains a major cause of mortality in children despite progress encountered in the last decades.
BMC Health Services Research (2019) 19:458 https://doi.org/10.1186/s12913-019-4315-7
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International Drug... Monitoring. This text was developed in consultation with the WHO Collaborating Centre for International Drug Monitoring and the national pharmacovigilance centres participating in the WHO Programme for International Drug Monitoring.
more